Tatva Chintan Pharma Chem

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue93.3387.2898.4695.2381.77
Expenses81.6280.7286.1893.0983.34
EBITDA21.5013.5218.729.115.40
EBIT14.726.9412.502.45-1.41
Profit Before Tax11.706.5612.282.14-1.58
Net Profit8.204.658.251.51-1.11
Financial Ratios
Operating Profit Margin23.23%15.71%19.94%9.72%6.68%
Net Profit Margin8.86%5.40%8.78%1.61%-1.37%
Earning Per Share (Diluted)3.631.993.520.64-0.47
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ